Skip to main content
Log in

The meta-analysis of cytogenetic biomarkers as an assessment of occupational risk for healthcare workers exposed to antineoplastic drugs

  • Review
  • Published:
International Archives of Occupational and Environmental Health Aims and scope Submit manuscript

Abstract

Objective

Antineoplastic drugs (ADs) are widely used in clinical practice and have been demonstrated to be effective in treating malignant tumors. However, they carry a risk of cytogenotoxicity for healthcare workers. Studies have reported that genotoxic biomarkers can be applied to assess the occupational health status of healthcare workers at an early stage, but results of different studies are variable. The objectives of the review were examine the association between long-term exposure to ADs and cytogenetic damage to healthcare workers.

Methods

We systematically reviewed studies between 2005 and 2021 using PubMed, Embase and Web of Science databases that used cytogenetic biomarkers to assess occupational exposure to ADs in healthcare workers. We used RevMan5.4 to analyze the tail length parameters of the DNA, frequency of the chromosomal aberrations, sister chromatid exchanges and micronuclei. A total of 16 studies were included in our study. The studies evaluate the quality of the literature through the Agency for Healthcare Research and Quality.

Results

The results revealed that under the random-effects model, the estimated standard deviation was 2.37 (95% confidence interval [CI] 0.92–3.81, P = 0.001) for the tail length parameters of the DNA, 1.48 (95% CI 0.71–2.25, P = 0.0002) for the frequency of chromosomal aberrations, 1.74 (95% CI 0.49–2.99, P = 0.006) for the frequency of sister chromatid exchanges and 1.64 (95% CI 0.83–2.45, P < 0.0001) for the frequency of micronuclei.

Conclusions

The results indicate that there is a significant association between occupational exposure to ADs and cytogenetic damage, to which healthcare workers should be alerted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Data availability

Data are available on reasonable request. Data cannot be made publicly available, because public availability would compromise participant privacy.

References

  • Bi J, Wang R (2018) The comparison of methods on the cytokinesis block micronucleus cell (CB-MNT) detection. Captial J Pub Health 12(02):109–111

    Google Scholar 

  • Bouraoui S, Brahem A, Tabka F et al (2011a) Assessment of chromosomal aberrations, micronuclei and proliferation rate index in peripheral lymphocytes from Tunisian nurses handling cytotoxic drugs. Environ Toxicol Pharmacol 31(1):250–257

    Article  CAS  Google Scholar 

  • Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424

    Article  Google Scholar 

  • Burgaz S, Karahalil B, Canhi Z et al (2002) Assessment of genotoxic damage in nurses occupationally exposed to antineoplastics by the analysis of chromosomal aberrations. Hum Exp Toxicol 21(3):129–135

    Article  CAS  Google Scholar 

  • Buschini A, Villarini M, Feretti D et al (2013) Multicentre study for the evaluation of mutagenic/carcinogenic risk in nurses exposed to antineoplastic drugs: assessment of DNA damage. Occup Environ Med 70(11):789–794

    Article  CAS  Google Scholar 

  • Chen W, Angao Xu, Zhang X (2017) Advances in the study of disease burden of malignant tumors. J Med Theory Pract 30(14):2062–2065

    Google Scholar 

  • Connor TH, Mcdiarmid MA (2006) Preventing occupational exposures to antineoplastic drugs in health care settings. CA Cancer J Clin 56(6):354–365

    Article  Google Scholar 

  • Connor TH, Debord G, Pretty JR et al (2010) Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers. J Occup Environ Med 52(10):1019–1027

    Article  Google Scholar 

  • Cornetta T, Padua L, Testa A et al (2008) Molecular biomonitoring of a population of nurses handling antineoplastic drugs. Mutat Res 638(1–2):75–82

    Article  CAS  Google Scholar 

  • El-Ebiary AA, Abuelfadl AA, Sarhan NI (2013) Evaluation of genotoxicity induced by exposure to antineoplastic drugs in lymphocytes of oncology nurses and pharmacists. J Appl Toxicol 33(3):196–201

    Article  Google Scholar 

  • Fakher HM, Metwally ES, Rabab Sh E-S (2021) The potential genotoxic effects of antineoplastic drugs in occupationally exposed nurses. Asia Pacific J Med Toxicol 10(1):60–66

    Google Scholar 

  • Goloni-Bertollo EM, Tajara EH, Manzato AJ et al (1992) Sister chromatid exchanges and chromosome aberrations in lymphocytes of nurses handling antineoplastic drugs. Int J Cancer 50(3):341–344

    Article  CAS  Google Scholar 

  • Huang X, Gao C, Cai W et al (2021a) Effect of occupational exposure to antineoplastic drugs on DNA damage in nurses: a cross-sectional study. Occup Environ Med. https://doi.org/10.1136/oemed-2021-107913

    Article  Google Scholar 

  • Huang C, Niu X, Gao C et al (2021b) Micronucleus analysis of peripheral blood lymphocytes in nurses with occupational exposure to antineoplastic drugs. Occup Health 37(04):458–462

    Google Scholar 

  • Kopjar N, Kasuba V, Rozgaj R et al (2009) The genotoxic risk in health care workers occupationally exposed to cytotoxic drugs–a comprehensive evaluation by the SCE assay. J Environ Sci Health A Tox Hazard Subst Environ Eng 44(5):462–479

    Article  CAS  Google Scholar 

  • Ladeira C, Viegas S, Pádua M et al (2014) Assessment of genotoxic effects in nurses handling cytostatic drugs. J Toxicol Environ Health Part A Curr Issues 77(14–16):879–887

    Article  CAS  Google Scholar 

  • Laffon B, Teixeira JP, Silva S et al (2005) Genotoxic effects in a population of nurses handling antineoplastic drugs, and relationship with genetic polymorphisms in DNA repair enzymes. Am J Ind Med 48(2):128–136

    Article  CAS  Google Scholar 

  • Li L (2017) Risk assessment of health effect on nurse occupationally exposed to antineoplastic drugs in shenzhen hospital. Zunyi Medical University, Zunyi

    Google Scholar 

  • Mahmoodi M, Soleyman-Jahi S, Zendehdel K et al (2017) Chromosomal aberrations, sister chromatid exchanges, and micronuclei in lymphocytes of oncology department personnel handling anti-neoplastic drugs. Drug Chem Toxicol 40(2):235–240

    Article  CAS  Google Scholar 

  • Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Lisy K, Qureshi R, Mattis P, Mu P (2020) Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z (eds) JBI manual for evidence synthesis. JBI. https://synthesismanual.jbi.global. https://doi.org/10.46658/JBIMES-20-08

  • Moretti M, Grollino MG, Pavanello S et al (2015) Micronuclei and chromosome aberrations in subjects occupationally exposed to antineoplastic drugs: a multicentric approach. Int Arch Occup Environ Health 88(6):683–695

    Article  CAS  Google Scholar 

  • Rekhadevi PV, Sailaja N, Chandrasekhar M et al (2007) Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs. Mutagenesis 22(6):395–401

    Article  CAS  Google Scholar 

  • Roussel C, Witt KL, Shaw PB et al (2019) Meta-analysis of chromosomal aberrations as a biomarker of exposure in healthcare workers occupationally exposed to antineoplastic drugs. Mutat Res Rev Mutat Res 781:207–217

    Article  CAS  Google Scholar 

  • Santovito A, Cervella P, Delpero M (2014) Chromosomal damage in peripheral blood lymphocytes from nurses occupationally exposed to chemicals. Hum Exp Toxicol 33(9):897–903

    Article  CAS  Google Scholar 

  • Sasaki M, Dakeishi M, Hoshi S et al (2008) Assessment of DNA damage in Japanese nurses handling antineoplastic drugs by the comet assay. J Occup Health 50(1):7–12

    Article  CAS  Google Scholar 

  • Shen X, Chen Y, Wen Z et al (2021) Research progress of automated micronucleus analysis technology for cytokinesis arrest. J Radiat Res Radiat 39(03):3–10

    Google Scholar 

  • Siegel RL, Miller KD, Jemal A (2020) Cancer statistics. CA Cancer J Clin 70(1):7–30

    Article  Google Scholar 

  • Suspiro A, Prista J (2011) Biomarkers of occupational exposure do anticancer agents: a minireview. Toxicol Lett 207(1):42–52

    Article  CAS  Google Scholar 

  • Testa A, Giachelia M, Palma S et al (2007) Occupational exposure to antineoplastic agents induces a high level of chromosome damage. Lack of an effect of GST polymorphisms. Toxicol Appl Pharmacol 223(1):46–55

    Article  CAS  Google Scholar 

  • Ursini CL, Cavallo D, Colombi A et al (2006) Evaluation of early DNA damage in healthcare workers handling antineoplastic drugs. Int Arch Occup Environ Health 80(2):134–140

    Article  CAS  Google Scholar 

  • Villarini M, Dominici L, Fatigoni C et al (2012) Biological effect monitoring in peripheral blood lymphocytes from subjects occupationally exposed to antineoplastic drugs: assessment of micronuclei frequency. J Occup Health 54(6):405–415

    Article  CAS  Google Scholar 

  • Xiao H (2019) Hazards of chemotherapy drugs to oncology nurses and occupational protection. Chin Commun Dr 35(28):130–132

    Google Scholar 

  • You Li, Fan Y, Liu Q et al (2010) Study on genetic damage in workers exposed to benzene. Chin J Ind Med 23(03):170–172

    Google Scholar 

  • Zare Sakhvidi MJ, Hajaghazadeh M, Mostaghaci M et al (2016) Applicability of the comet assay in evaluation of DNA damage in healthcare providers’ working with antineoplastic drugs: a systematic review and meta-analysis. Int J Occup Environ Health 22(1):52–67

    Article  CAS  Google Scholar 

  • Zheng Ke, Pan J, Jiang Z et al (2002) The principle of sister chromatid exchange(SCE) detection and its molecular mechanism. Chin J Cell Biol 06:355–359

    Google Scholar 

Download references

Acknowledgements

We thank Drs.XiaoHong Huang and Yeqing Gu for providing a careful review of the manuscript and helpful comments.

Funding

This work was supported by the special fund for the association between exposure to antineoplastic agents and genotoxicity of female healthcare workers [LGWJ2021-14].

Author information

Authors and Affiliations

Authors

Contributions

HH, YG and XH contributed to the study conception and design; HH, YG, SL, SH, XZ, YH and JP contributed to data collection, assembly, analysis and interpretation of the data; HH, YG and XH contributed to the manuscript drafting and revising. All authors approved the final version of the manuscript. HH was responsible for the overall content as guarantor.

Corresponding author

Correspondence to Xiaohong Huang.

Ethics declarations

Conflict of interest

The authors have nothing to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 14 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, H., Gu, Y., Liu, S. et al. The meta-analysis of cytogenetic biomarkers as an assessment of occupational risk for healthcare workers exposed to antineoplastic drugs. Int Arch Occup Environ Health 96, 785–796 (2023). https://doi.org/10.1007/s00420-023-01969-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00420-023-01969-6

Keywords

Navigation